FRIEDMAN PAUL A — SEC Form 4 filings
SEC reporting owner CIK 1236927. 15 Form 4 filings on record with FilingPulse; latest filed 2026-06-10.
Transaction summary — filings shown
Covers all 15 filings on record, filed 2024-01-18 to 2026-06-10. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 104 legs across 9 filings — 355,856 shares, $126,255,181 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 34.
- Largest priced transaction: sale of 28,976 shares @ $372.39 ($10,790,486) in MADRIGAL PHARMACEUTICALS, INC., filed 2025-08-13.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Director | 12 | — | 104 legs · 355,856 sh · $126,255,181 | 31 |
| Prelude Therapeutics Inc (PRLD) | Director | 3 | — | — | 3 |
Form 4 filings — FRIEDMAN PAUL A
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-10 | 4 | Prelude Therapeutics Inc (PRLD) | Grant/award (A): 38,000 (derivative) @ $0 | EDGAR |
| 2026-01-13 | 4 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Option exercise (M): 24,520 @ $15.80 · Sale (S): 1,480 @ $511.98 · Sale (S): 1,094 @ $513.11 · Sale (S): 1,345 @ $514.68 · Sale (S): 1,996 @ $515.81 · Sale (S): 766 @ $516.84 · +24 more | EDGAR |
| 2026-01-13 | 4 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Option exercise (M): 280 @ $15.80 · Sale (S): 280 @ $551.24 · Option exercise (M): 280 (derivative) @ $0 | EDGAR |
| 2025-12-12 | 4 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Option exercise (M): 24,800 @ $15.80 · Sale (S): 624 @ $547.75 · Sale (S): 535 @ $548.51 · Sale (S): 409 @ $549.99 · Sale (S): 4,316 @ $550.93 · Sale (S): 7,193 @ $551.67 · +5 more | EDGAR |
| 2025-08-13 | 4 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Option exercise (M): 3,203 @ $9.45 · Sale (S): 2,903 @ $350.19 · Sale (S): 300 @ $351.04 · Option exercise (M): 43,605 @ $9.45 · Sale (S): 3,303 @ $350.93 · Sale (S): 3,202 @ $351.59 · +10 more | EDGAR |
| 2025-08-13 | 4 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Option exercise (M): 129,172 @ $9.45 · Sale (S): 1,600 @ $358.23 · Sale (S): 455 @ $359.31 · Sale (S): 3,153 @ $360.27 · Sale (S): 1,754 @ $361.13 · Sale (S): 1,439 @ $362.29 · +13 more | EDGAR |
| 2025-07-22 | 4 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Option exercise (M): 1,400 @ $9.45 · Sale (S): 1,400 @ $350.03 · Option exercise (M): 1,400 (derivative) @ $0 | EDGAR |
| 2025-07-18 | 4 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Option exercise (M): 26,176 @ $9.45 · Sale (S): 5,541 @ $350.17 · Sale (S): 2,371 @ $351.38 · Sale (S): 2,110 @ $352.67 · Sale (S): 2,319 @ $353.82 · Sale (S): 6,851 @ $354.65 · +7 more | EDGAR |
| 2025-06-24 | 4 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Grant/award (A): 715 @ $0 · Grant/award (A): 1,290 (derivative) @ $0 | EDGAR |
| 2025-06-13 | 4 | Prelude Therapeutics Inc (PRLD) | Grant/award (A): 38,000 (derivative) @ $0 | EDGAR |
| 2024-06-27 | 4 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Grant/award (A): 714 @ $0 · Grant/award (A): 1,105 (derivative) @ $0 | EDGAR |
| 2024-06-18 | 4 | Prelude Therapeutics Inc (PRLD) | Grant/award (A): 23,500 (derivative) @ $0 | EDGAR |
| 2024-04-10 | 4 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Option exercise (M): 26,270 @ $9.45 · Sale (S): 1,441 @ $242.95 · Sale (S): 3,730 @ $244.12 · Sale (S): 5,663 @ $244.86 · Sale (S): 2,078 @ $245.71 · Sale (S): 5,028 @ $246.96 · +3 more | EDGAR |
| 2024-04-05 | 4 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Option exercise (M): 27,407 @ $9.45 · Sale (S): 185 @ $242 · Sale (S): 2,294 @ $243.64 · Sale (S): 4,301 @ $244.58 · Sale (S): 18,806 @ $245.34 · Sale (S): 1,821 @ $246.31 · +20 more | EDGAR |
| 2024-01-18 | 4 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Tax withholding (F): 2,254 @ $243.92 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1236927 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →